![Jonathan Lieber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Lieber
Directeur Financier/CFO chez
RALLYBIO CORPORATION
Fortune : 701 937 $ au 31/10/2026
Profil
Mr. Jonathan I.
Lieber is a Chief Financial Officer at Bambusa Therapeutics, Inc., an Independent Director at MindWalk Holdings Corp., a Chief Financial Officer & Treasurer at Rallybio Corp., an Independent Director at Decoy Therapeutics, Inc. and a Member-Audit Committee at Atrius Health, Inc. He is on the Board of Directors at MindWalk Holdings Corp.
and Decoy Therapeutics, Inc. Mr. Lieber was previously employed as a Chief Financial Officer by Applied Genetic Technologies Corp., a President & Chief Financial Officer by Organovo Holdings, Inc., an Independent Director by Salarius Pharmaceuticals, Inc., a Chief Financial Officer by Checkmate Pharmaceuticals, Inc., a Chief Financial Officer by Danforth Advisors LLC, a Chief Financial Officer by Histogenics Corp., a Chief Financial Officer & Senior Vice President by Metamark Genetics, Inc., a Chief Financial Officer & Treasurer by Repligen Corp., a Chief Financial Officer & Treasurer by Xcellerex, Inc., a Chief Financial Officer, Treasurer & Senior VP by Altus Pharmaceuticals, Inc., a Vice President by SG Cowen & Co. LLC, and a Member-Health Care & High Yield Group by Salomon Brothers, Inc. He received his undergraduate degree from Boston University and an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RALLYBIO CORPORATION 0,82 % | 02/11/2026 | 44 139 ( 0,82 % ) | 685 920 $ | 31/10/2026 |
MINDWALK HOLDINGS CORP. 0,03 % | 03/09/2026 | 12 279 ( 0,03 % ) | 13 875 $ | 31/10/2026 |
0,08 % | 31/08/2026 | 2 002 ( 0,08 % ) | 2 142 $ | 31/10/2026 |
Postes actifs de Jonathan Lieber
| Sociétés | Poste | Début |
|---|---|---|
| RALLYBIO CORPORATION | Directeur Financier/CFO | 01/02/2023 |
| MINDWALK HOLDINGS CORP. | Directeur/Membre du Conseil | 07/07/2025 |
Atrius Health, Inc.
 Atrius Health, Inc. Medical/Nursing ServicesHealth Services Provides primary and specialty care services | Corporate Officer/Principal | - |
Anciens postes connus de Jonathan Lieber
| Sociétés | Poste | Fin |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Directeur Financier/CFO | 30/11/2022 |
| VIVOSIM LABS, INC. | Directeur Financier/CFO | 06/10/2021 |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic biotechnology consulting services for corporate, clinical & commercial sectors | Directeur Général | 07/04/2021 |
| CHECKMATE PHARMACEUTICALS, INC. | Directeur Financier/CFO | 04/01/2021 |
| OCUGEN, INC. | Directeur Financier/CFO | 01/09/2019 |
Formation de Jonathan Lieber
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Xcellerex, Inc.
 Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Offers contract services for bioprocess development and manufacturing | Health Technology |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
VivoSim Labs, Inc.
 VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Salomon Brothers, Inc.
 Salomon Brothers, Inc. Investment Banks/BrokersFinance Investment banking services | Finance |
Atrius Health, Inc.
Atrius Health, Inc. Medical/Nursing ServicesHealth Services Provides primary and specialty care services | Health Services |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic biotechnology consulting services for corporate, clinical & commercial sectors | Commercial Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
ImmunoPrecise Antibodies Ltd.
 ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
Salarius Pharmaceuticals, Inc.
 Salarius Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on developing treatment for cancer | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
